UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Vimentin in cancer and its potential as a molecular target for cancer therapy

Cellular and molecular life sciences : CMLS, 2011-09, Vol.68 (18), p.3033-3046

2011

Volltextzugriff (PDF)

Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients

Scientific reports, 2016-07, Vol.6 (1), p.28910-28910, Article 28910

2016

Volltextzugriff (PDF)

Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression

Clinical cancer research, 2015-02, Vol.21 (4), p.899-906

2015

Volltextzugriff (PDF)

Cell‐surface Vimentin: A mislocalized protein for isolating csVimentin+CD133− novel stem‐like hepatocellular carcinoma cells expressing EMT markers

International journal of cancer, 2015-07, Vol.137 (2), p.491-496

2015

Volltextzugriff (PDF)

IL‐30 (IL27p28) attenuates liver fibrosis through inducing NKG2D‐rae1 interaction between NKT and activated hepatic stellate cells in mice

Hepatology (Baltimore, Md.), 2014-12, Vol.60 (6), p.2027-2039

2014

Volltextzugriff (PDF)

Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells

Cancer research (Chicago, Ill.), 2014-03, Vol.74 (6), p.1645-1650

2014

Volltextzugriff (PDF)

Cell surface vimentin‐positive circulating tumor cell‐based relapse prediction in a long‐term longitudinal study of postremission neuroblastoma patients

International journal of cancer, 2020-12, Vol.147 (12), p.3550-3559

2020

Volltextzugriff (PDF)

Galectin‐4 functions as a tumor suppressor of human colorectal cancer

International journal of cancer, 2011-08, Vol.129 (4), p.799-809

2011

Volltextzugriff (PDF)

Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line-specific apoptotic mechanisms

International journal of cancer, 2012-06, Vol.130 (11), p.2703-2714

2012

Volltextzugriff (PDF)

Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas

Frontiers in oncology, 2021-12, Vol.11, p.760267-760267

2021

Volltextzugriff (PDF)

Intricacies for Posttranslational Tumor-Targeted Cytokine Gene Therapy

Mediators of Inflammation, 2013-01, Vol.2013, p.378971-9

2013

Volltextzugriff (PDF)

959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses – clinical update on the ACTengine® IMA203 trial

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A1009-A1009

2021

Volltextzugriff (PDF)

Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response

Clinical chemistry (Baltimore, Md.), 2015-01, Vol.61 (1), p.259-266

2015

Volltextzugriff (PDF)

RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathways

Proteomics (Weinheim), 2009-05, Vol.9 (10), p.2776-2787

2009

Volltextzugriff (PDF)

EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression

Oncotarget, 2017-07, Vol.8 (30), p.49329-49337

2017

Volltextzugriff (PDF)

Vimentin as a potential molecular target in cancer therapy Or Vimentin, an overview and its potential as a molecular target for cancer therapy

Cellular and molecular life sciences : CMLS, 2011-06, Vol.68 (18), p.3033-3046

2011

Volltextzugriff (PDF)

Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells

Cell communication and signaling, 2015-02, Vol.13 (1), p.14-14, Article 14

2015

Volltextzugriff (PDF)

Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells

Journal of Cancer, 2016-01, Vol.7 (13), p.1824-1832

2016

Volltextzugriff (PDF)

Abstract 662: IMA_Detect: Mass spectrometry guided development and clinical application of a companion diagnostic for adoptive cellular therapy against tumor associated HLA peptides

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.662-662

2018

Volltextzugriff (PDF)

Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection

Proteomics (Weinheim), 2018-06, Vol.18 (12), p.e1700284-n/a

2018

Volltextzugriff (PDF)

Abstract 1924: Discovery and characterization of EMT positive and chemo-resistant novel population of HCC like stem cells

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1924-1924

2014

Volltextzugriff (PDF)

Cell Surface Vimentin Positive Circulating Tumor Cell-Based Relapse Prediction in a Long-Term Longitudinal Study of Post-Remission Neuroblastoma Patients

International journal of cancer, 2020-06, Vol.147 (12), p.3550-3559

2020

Volltextzugriff (PDF)

Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells

Cancer letters, 2011-02, Vol.301 (1), p.38-46

2011

Volltextzugriff (PDF)

Abstract 1596: Detection of PD-L1 in cell surface vimentin positive circulating tumor cells is associated with poor survival in cancer patients

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1596-1596

2015

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vimentin in cancer and its potential as a molecular target for cancer therapy

Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients

Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression

Cell‐surface Vimentin: A mislocalized protein for isolating csVimentin+CD133− novel stem‐like hepatocellular carcinoma cells expressing EMT markers

IL‐30 (IL27p28) attenuates liver fibrosis through inducing NKG2D‐rae1 interaction between NKT and activated hepatic stellate cells in mice

Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells

Cell surface vimentin‐positive circulating tumor cell‐based relapse prediction in a long‐term longitudinal study of postremission neuroblastoma patients

Galectin‐4 functions as a tumor suppressor of human colorectal cancer

Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line-specific apoptotic mechanisms

Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas

First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors

Intricacies for Posttranslational Tumor-Targeted Cytokine Gene Therapy

959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses – clinical update on the ACTengine® IMA203 trial

Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response

RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathways

EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression

Vimentin as a potential molecular target in cancer therapy Or Vimentin, an overview and its potential as a molecular target for cancer therapy

Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells

Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells

Abstract 662: IMA_Detect: Mass spectrometry guided development and clinical application of a companion diagnostic for adoptive cellular therapy against tumor associated HLA peptides

Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection

Abstract 1924: Discovery and characterization of EMT positive and chemo-resistant novel population of HCC like stem cells

Cell Surface Vimentin Positive Circulating Tumor Cell-Based Relapse Prediction in a Long-Term Longitudinal Study of Post-Remission Neuroblastoma Patients

Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells

Abstract 1596: Detection of PD-L1 in cell surface vimentin positive circulating tumor cells is associated with poor survival in cancer patients

Suchergebnisse filtern